⌘K

Home/Filings/4/0001209191-23-025294

4//SEC Filing

Dagnon Terry 4

Accession 0001209191-23-025294

CIK 0001649989other

View on SEC.gov Company Profile

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 9:05 PM ET

Size

5.0 KB

Accession

0001209191-23-025294

Insider Transaction Report

Form 4

Period: 2023-04-20

Outlook Therapeutics, Inc.OTLK

Chief Operating Officer

Transactions

Sale
Common Stock
2023-04-20$1.14/sh−520,000$590,200→ 653,058 total

Footnotes (1)

[F1]These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 75% of the shares as provided in that certain Consulting Agreement dated January 27, 2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Outlook Therapeutics, Inc.

CIK 0001649989

Entity typeother

Related Parties

1

filerCIK 0001760510

Filing Metadata

Form type: 4
Filed: Apr 20, 8:00 PM ET
Accepted: Apr 21, 9:05 PM ET
Size: 5.0 KB

View on SEC.gov